After the FDA gave emergency approval for the use of therapeutic plasma exchange in treatment for SARS‐Coronoavirus‐2, we analyzed its efficacy in patients who had failed all other known therapies. Click to show full abstract
After the FDA gave emergency approval for the use of therapeutic plasma exchange in treatment for SARS‐Coronoavirus‐2, we analyzed its efficacy in patients who had failed all other known therapies.
               
Click one of the above tabs to view related content.